Regulatory & Legal

Structure Therapeutics reports strong Phase 2 data for its oral obesity pill, aleniglipron, positioning it as a key contender in the race for pill-based GLP-1s.

FTAI Infrastructure's aggressive acquisitions drove an 82% jump in adjusted earnings, but hefty debt and transaction costs led to a significant net loss.

A new study shows alternating magnetic fields can destroy antibiotic-resistant biofilms on medical implants, offering hope for a non-surgical treatment.

Over 1,500 traders have given $6.1M to AI agents in a 21-day DeFi deathmatch where only one token survives. Is this the future or financial insanity?

With clinical results converging, a new report reveals the real GLP-1 battle is fought in patent filings, not labs, deciding who wins this $100B+ market.

With its 'Women Who Inspire' campaign and a major brand refresh, Dress for Success is tackling global workforce disparities with a bold new vision.

A new report reveals the cost of a basic American life rose 4.4% in 2024, outpacing wages due to soaring housing and childcare expenses.

A landmark partnership between US entrepreneurs and a top Kenyan university aims to equip a new generation to own and scale Africa's booming creative sector.

A century-old Chicago food dynasty, Pastorelli Food Products, sees its iconic recipes and brand name hit the auction block in a $2.8M foreclosure sale.

As wildfire losses soar, new actuarial guidelines aim to reshape Canada's insurance landscape. What does this mean for your policy and premiums?

As AI assistants reshape search, many top brands are invisible. A new AI Authority Index aims to fix this 'clarity problem' before it's too late.

A C$44M investment from giants AngloGold Ashanti and Centerra Gold validates Thesis Gold & Silver's BC project, signaling a new era for the region.

A new global alliance aims to solve the costly patient adherence problem by merging world-class marketing with a proven, AI-powered digital health platform.

Sarepta will unveil crucial long-term data for its Duchenne gene therapy and exon-skipping drugs at MDA 2026, a pivotal moment for patients and the company.

A key partnership ensures the supply of a breakthrough therapy for FOP, a devastating condition where muscle turns to bone, highlighting a new era in drug production.

The Swedish freight-tech firm secures new funding for its SPAC merger, fueling a global push for its electric and autonomous trucking ecosystem.

Beyond software, an Upstate NY incubator is tackling global challenges in health, climate, and ag-tech, turning physical ideas into world-changing products.

The 401(k) provider hires sales and regulatory leaders to capitalize on surging demand from small businesses and navigate complex new retirement laws.

A new skincare brand is skipping mass marketing, embedding its products with veterans, skiers, and melanoma researchers to redefine sun protection.

Flexport launches a suite of AI tools to audit customs, optimize shipping, and process tariff refunds, aiming to create a fully autonomous supply chain.